Management of a drug–drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma

aEA 3920 Université de Franche-Comté

bService de Pharmacologie Clinique et Toxicologie, CHU de Besançon, Besançon

cService de maladies infectieuses, Centre Hospitalier William Morey, Chalon sur Saône, France.

Correspondence to Jennifer Lagoutte-Renosi, CHU de Besançon, Service de Pharmacologie Clinique et Toxicologie, 3, Boulevard Fleming, 25030 Besançon Cedex, France. Tel: +33 0 3 70 63 23 79; fax: +33 0 3 70 63 21 05; e-mail: [email protected]

Received 24 August, 2022

Revised 19 January, 2023

Accepted 10 February, 2023

留言 (0)

沒有登入
gif